Feature | Cardiovascular Ultrasound | Dave Fornell, Editor
The higher expense and lower frame rates of 3-D cardiac ultrasound systems have limited their adoption over the past ...
January 31, 2019
News | Cardiac Diagnostics
January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type of ...
January 31, 2019
News | Cath Lab
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack. The study, published in Cell Metabolism, demonstrates for the first time that the metabolism of dead heart cells by macrophages reprograms the immune cells to launch an anti-inflammatory response and stimulate tissue repair.
January 30, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Congenital Heart
Rising temperatures stemming from global climate change may increase the number of infants born with congenital heart defects (CHD) in the U.S. over the next two decades, according to new research in the Journal of the American Heart Association.1 This may also result in as many as 7,000 additional cases over an 11 year-period in eight representative states — Arkansas, Texas, California, Iowa, North Carolina, Georgia, New York and Utah.
January 30, 2019
Feature | Atrial Fibrillation
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
January 30, 2019
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor
In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...
January 30, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology | Magnetic Resonance Imaging (MRI)
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers.
January 30, 2019
Technology | Chronic Total Occlusion (CTO)
XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the U.S. Food and Drug Administration (FDA) as peripheral crossing catheters. The catheters have been safely and successfully used to cross challenging lesions in both arterial chronic total occlusions (CTOs) and chronic obstructive venous lesions. The recent crossing FDA clearance adds to the previous clearances for endovascular support.
January 30, 2019
News | Heart Valve Technology
Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their transcatheter aortic valve implantation (TAVI) system.
January 29, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Heart Valve Technology
LivaNova PLC announced the publication of three separate studies highlighting the performance of its sutureless aortic valve, Perceval.
January 29, 2019
Feature | Stents | Dave Fornell, Editor
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...
January 29, 2019
Videos | Artificial Intelligence
DAIC Editor Dave Fornell takes a tour of some of the most interesting new artificial intelligence (AI) imaging ...
January 28, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Cardio-oncology
The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology Patient course in Washington on Jan. 25-27, 2019. The event brought together top experts in both cardiology and oncology to review new and relevant science in this rapidly evolving field.
January 28, 2019
Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac imaging and mapping visualization system in persistent atrial fibrillation (AF) ablation procedures. Results presented at the 24th Annual AF Symposium, Jan. 24-26 in Boston, show the use of AcQMap resulted in 72.5 percent single-procedure freedom from AF at 12 months. Rigorous post-ablation monitoring showed 89.6 percent of the single-procedure patients experienced zero episodes of AF.
January 28, 2019
Feature | Angiography | Dave Fornell, Editor
There are a few recent trends in X-ray angiography imaging systems that hospitals should be aware of if they are looking ...
January 28, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now